3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
3
Gastrointestinal
3
Thoracic
2
Head & Neck
2
Breast
2
Other neoplasm
1
Conditions
Rectal Neoplasms
1
Precancerous Conditions
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Adenomatous Polyps
1
Interventions
Cyclophosphamide
13
Peripheral Blood Stem Cell Transplantation
9
Biopsy
9
fludarabine phosphate
8
Busulfan
8
Whole-Body Irradiation
7
Surveys and Questionnaires
6
Mycophenolic Acid
6
Educational Status
6
Early Intervention, Educational
6
Carboplatin
6
fludarabine
5
Tacrolimus
5
Paclitaxel
5
Methotrexate
5
Methods
5
Melphalan
5
Epoetin Alfa
5
Decitabine
5
Cyclosporine
5
Colposcopy
5
Cisplatin
5
Celecoxib
5
Antilymphocyte Serum
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Radiotherapy
4
Patient Reported Outcome Measures
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
alpha-Tocopherol
×
Other neoplasm
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts